Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 19, 2020
STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype
Carminia M Della Corte, Triparna Sen, Carl M Gay, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2020
Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology
C Allison Stewart, Carl M Gay, Kavya Ramkumar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 18, 2021
Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2-Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology
C Allison Stewart, Carl M Gay, Kavya Ramkumar, et al.
Cancer Cell
|
February 17, 2024
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
Barzin Y Nabet, Habib Hamidi, Myung Chang Lee, et al.
British Journal of Cancer
|
April 20, 2022
Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer
Bingnan Zhang, C Allison Stewart, Qi Wang, et al.
Lancet (London, England)
|
July 21, 2023
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial
Joe Y Chang, Steven H Lin, Wenli Dong, et al.
NPJ Precision Oncology
|
November 18, 2024
Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms
Alejandra G Serrano, Pedro Rocha, Cibelle Freitas Lima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2024
YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities
C Allison Stewart, Lixia Diao, Yuanxin Xi, et al.
Cancer Cell
|
January 22, 2021
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
Carl M Gay, C Allison Stewart, Elizabeth M Park, et al.
Cancers
|
December 11, 2025
MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer
Hui Li, Lingzhi Hong, Pedro Rocha, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 19, 2020
STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype
Carminia M Della Corte, Triparna Sen, Carl M Gay, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2020
Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology
C Allison Stewart, Carl M Gay, Kavya Ramkumar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 18, 2021
Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2-Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology
C Allison Stewart, Carl M Gay, Kavya Ramkumar, et al.
Cancer Cell
|
February 17, 2024
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
Barzin Y Nabet, Habib Hamidi, Myung Chang Lee, et al.
British Journal of Cancer
|
April 20, 2022
Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer
Bingnan Zhang, C Allison Stewart, Qi Wang, et al.
Lancet (London, England)
|
July 21, 2023
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial
Joe Y Chang, Steven H Lin, Wenli Dong, et al.
NPJ Precision Oncology
|
November 18, 2024
Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms
Alejandra G Serrano, Pedro Rocha, Cibelle Freitas Lima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2024
YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities
C Allison Stewart, Lixia Diao, Yuanxin Xi, et al.
Cancer Cell
|
January 22, 2021
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
Carl M Gay, C Allison Stewart, Elizabeth M Park, et al.
Cancers
|
December 11, 2025
MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer
Hui Li, Lingzhi Hong, Pedro Rocha, et al.
Page
of 9